Global Antibiotic Research and Development Partnership: The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to collaborate on new projects to address antimicrobial resistance (AMR) for the benefit of public health. Since 2018, GARDP and the University of Liverpool have been working together to advance new treatment options for newborns with sepsis. Their research—published in leading peer-reviewed journals such as Archives of Disease in Childhood and the Journal of Antimicrobial Chemotherapy—has laid the groundwork for GARDP’s upcoming global clinical trial on neonatal sepsis. The trial will rank the safety and effectiveness
Global Antibiotic Research and Development Partnership as seen on The Hippocratic Post.